Evidence map›Paper›PMID 31265543›Full record

ArticleNeoplasia (New York, N.Y.)2016

Corrigendum to "PIAS1-FAK Interaction Promotes the Survival and Progression of Non-Small Cell Lung Cancer" [

Jerfiz D Constanzo, Ke-Jing Tang, Smita Rindhe, Margherita Melegari, Hui Liu, Ximing Tang, Jaime Rodriguez-Canales, Ignacio Wistuba, Pier Paolo Scaglioni

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Neoplasia (New York, N.Y.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Jerfiz D ConstanzoDepartment of Internal Medicine and Simmons, Comprehensive Cancer Center, University of Texas, Southwestern Medical Center, Dallas, TX, USA.
Ke-Jing TangDepartment of Internal Medicine and Simmons, Comprehensive Cancer Center, University of Texas, Southwestern Medical Center, Dallas, TX, USA.
Smita RindheDepartment of Internal Medicine and Simmons, Comprehensive Cancer Center, University of Texas, Southwestern Medical Center, Dallas, TX, USA.
Margherita MelegariDepartment of Internal Medicine and Simmons, Comprehensive Cancer Center, University of Texas, Southwestern Medical Center, Dallas, TX, USA.
Hui LiuDepartment of Translational Molecular Pathology, Head & Neck Medical Oncology, The University of Texas MD, Anderson Cancer Center, Houston, TX, USA.
Ximing TangDepartment of Translational Molecular Pathology, Head & Neck Medical Oncology, The University of Texas MD, Anderson Cancer Center, Houston, TX, USA.
Jaime Rodriguez-CanalesDepartment of Translational Molecular Pathology, Head & Neck Medical Oncology, The University of Texas MD, Anderson Cancer Center, Houston, TX, USA.
Ignacio WistubaDepartment of Translational Molecular Pathology, Head & Neck Medical Oncology, The University of Texas MD, Anderson Cancer Center, Houston, TX, USA.
Pier Paolo ScaglioniDepartment of Internal Medicine and Simmons, Comprehensive Cancer Center, University of Texas, Southwestern Medical Center, Dallas, TX, USA.
The University of Texas Southwestern Medical Center · USThe University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.neo.2016.03.003.].

Identifiers

PMID31265543
PMCPMC4954933
OpenAlexW2486598120

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.